Cameron Wheeler

Insider Reports History

Location
C/O Homology Medicines, Inc., 45 Wiggins Avenue, Bedford, MA
Signature
/s/ Nathan N. McConarty, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cameron Wheeler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. Director Class A Common Stock 5.15K $343K $66.72 Jun 18, 2025 Direct
Nuvalent, Inc. Director Stock Option (Right to Buy) 4.15K Jun 18, 2025 Direct

Insider Reports Filed by Cameron Wheeler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NUVL Nuvalent, Inc. Jun 18, 2025 2 $0 4 Jun 20, 2025 Director
NUVL Nuvalent, Inc. Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
NUVL Nuvalent, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
NUVL Nuvalent, Inc. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
NUVL Nuvalent, Inc. Jul 28, 2021 1 $0 4 Jul 30, 2021 Director
NUVL Nuvalent, Inc. Jul 28, 2021 0 $0 3 Jul 28, 2021 Director